Author:
Garcia Yhasmine Delles Oliveira,Mesquita Juliene Lima,Rosales Yensy Mariana Zelaya,Santos Tallyta Ellen Jesus dos,Moura Anna Thawanny Gadelha,Duarte João Vitor Araújo,Duarte Beatrice Araújo,Velloso Elvira Deolinda Rodrigues Pereira,Filho Francisco Dario Rocha,Duarte Fernando Barroso,Lemes Romélia Pinheiro Gonçalves, , , , , , , , , , ,
Funder
This article is published under the Creative Commons Attribution Non-commercial License.
Publisher
Touch Medical Media, Ltd.
Reference27 articles.
1. Bargotya M, Mehta A, Dutt S, et al. Myelodysplastic Syndrome (MDS) with isolated 5q deletion (5q-syndrome): report of two cases with review of literature. J Pathol. 2018;7:1.
2. Sperling AS, Gibson CJ, Ebert BL. The genetics of myelodysplastic syndrome: from clonal hematopoiesis to secondary leukemia. Nat Rev Cancer. 2017;17:5-19
3. Pacheco, LF. Myelodysplastic syndrome and response to homeopathic treatment: case report. Rev. Homeopatía. 2018:81:16–24.
4. Luskin MR, Abel GA. Management of older adults with myelodysplastic syndromes (MDS). J Geriatr Oncol. 2018;9:302–7.
5. Duarte FB. Estudo molecular do gene TP53 e da expressão da proteína p53 nas características prognósticas de pacientes com síndrome mielodisplásica de baixo risco. 2016. 78 f. Tese (Doutorado em Cirurgia ) - Universidade Federal do Ceará, Fortaleza, 2016.